Send to:

Choose Destination
See comment in PubMed Commons below
Anticancer Res. 1989 Mar-Apr;9(2):469-74.

Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines.

Author information

  • 1Department of Pediatrics, University of Toronto, Ontario, Canada.


Chemosensivity testing in 11 retinoblastoma (RB) cell lines identified five tumors showing cross-resistance to plant alkaloids, alkylating agents, anthracycline antibiotics, and antimetabolites, suggestive of the multidrug-resistant (MDR) phenotype described in other tumors. Only two tumors had been clinically exposed to chemotherapy, and both showed MDR. All RB tumors were resistant to clinically achievable concentrations of methotrexate and hydrocortisone, and only sensitive to cytosine arabinoside. These results provide a rational basis on which to develop new chemotherapeutic strategies for the treatment of RB.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk